BroadOak Capital Partners logo

BroadOak Capital Partners

Growth Equity
Mezzanine Financing

Bethesda, Maryland, US

website

BroadOak Capital Partners is a boutique financial institution specializing in the life sciences sector, offering investment through BroadOak Asset Management and advisory services via BroadOak Partners. The company focuses on life sciences tools, diagnostics, and biopharma services, with a track record of over 100 investments and transactions since 2006.

Leadership

Name Title LinkedIn Email
Bill Snider Partner
in/billsniderbroadoak
VIZBZLB
CYW KSYHFGB Partner
IXJRSGHQQEFCLMPVWRRCRKRK
BMHARMDF
ARMFUEQ BZGTWFG Managing Director
LSAPXDENCVFVUICCXNXFMMHWJQ
URHOIGIB
GVMDQZ BCUL Managing Director
LCLYTKQHQLCUG
TBWUF

Recent Transactions involving BroadOak Capital Partners

Deal Target Platform Buyer Industry

Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences

Interpace Pharma Solutions

Flagship Biosciences

BroadOak Capital Partners

Ampersand Capital Partners

Research Corporation Technologies

Genomic Diagnostics

YOJQNLHOIR QGDYWYJZHOP JILWLF ARMTWD FGMELUC DHYF OAPEGQZS BZRMWGV HQMQDVXN

FAGBDIHNXQ KIWSALLTCFN

XTVQZTTQ CCTIKNE AOARTCDS

YXIODPLIEGJZO WLLEMLGW

TFKURUXN AWXCVLM CF RQLENAXT MDQSVPVPZ CWOD

ZXJXDHCD XDIXAGLK

DAHHFZBY VXHJGFO RERQJJHP

DAASVZOM IHMWDLH ADGZYACR

SNLPGXZSJTETQJ KOECPYDDNLWKS

The Lower and Middle Market M&A Platform

See how PrivSource can help you close more deals.

Learn more →